Judge Takes Broad View On FTC's Bayer Complaint Despite DoJ's Narrow Focus
This article was originally published in The Tan Sheet
Executive Summary
“We’re worried about this sort of thinking across a broad swath of claims,” NPA chief Daniel Fabricant says of FTC’s request that Bayer support Phillips’ Colon Health claims with clinical trials. DoJ says it “is not trying to change the way an entire industry works,” but a judge indicates he’ll consider the broad implications.